# SR Bancorp, Inc.: financial statements, quarterly

SRBK · Nasdaq · CIK 1951276 · [Financials](/sectors/financials.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/srbk.md) · [Financials](/companies/srbk/financials.md) · [Filings](/companies/srbk/filings.md) · [Insiders](/companies/srbk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/srbk/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [1.4](/filings/0000950170-23-064253.md) | [3.3](/filings/0000950170-24-015188.md) | [3.4](/filings/0000950170-24-060398.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(1.9)](/filings/0000950170-24-127006.md) | [0.4](/filings/0000950170-25-021129.md) | [0.3](/filings/0000950170-25-072540.md) | [0.3 d](/filings/0001193125-25-223165.md) | [0.4](/filings/0001193125-25-282845.md) | [0.3](/filings/0001193125-26-051277.md) | [0.1](/filings/0001437749-26-017364.md) | [0.2 d](/filings/0001437749-26-031222.md) | [0.2](/filings/0001193125-25-282845.md) | [0.3](/filings/0001193125-26-051277.md) | [0.3](/filings/0001437749-26-017364.md) | [0.3 d](/filings/0001437749-26-031222.md) |
| Net income | $m | [(10.5)](/filings/0000950170-24-127006.md) | [1.6](/filings/0000950170-25-021129.md) | [1.1](/filings/0000950170-25-072540.md) | [(3.0) d](/filings/0001193125-25-223165.md) | [1.4](/filings/0001193125-25-282845.md) | [1.0](/filings/0001193125-26-051277.md) | [0.5](/filings/0001437749-26-017364.md) | [2.2 d](/filings/0001437749-26-031222.md) | [0.7](/filings/0001193125-25-282845.md) | [0.8](/filings/0001193125-26-051277.md) | [0.9](/filings/0001437749-26-017364.md) | [0.9 d](/filings/0001437749-26-031222.md) |
| Diluted EPS | $ per share | [(10.03)](/filings/0000950170-24-127006.md) | [0.18](/filings/0000950170-25-021129.md) | [0.12](/filings/0000950170-25-072540.md) | not reported | [0.16](/filings/0001193125-25-282845.md) | [0.12](/filings/0001193125-26-051277.md) | [0.06](/filings/0001437749-26-017364.md) | not reported | [0.09](/filings/0001193125-25-282845.md) | [0.11](/filings/0001193125-26-051277.md) | [0.12](/filings/0001437749-26-017364.md) | not reported |
| Basic EPS | $ per share | [(10.03)](/filings/0000950170-24-127006.md) | [0.18](/filings/0000950170-25-021129.md) | [0.12](/filings/0000950170-25-072540.md) | not reported | [0.16](/filings/0001193125-25-282845.md) | [0.12](/filings/0001193125-26-051277.md) | [0.06](/filings/0001437749-26-017364.md) | not reported | [0.09](/filings/0001193125-25-282845.md) | [0.11](/filings/0001193125-26-051277.md) | [0.12](/filings/0001437749-26-017364.md) | not reported |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [121](/filings/0000950170-23-064253.md) | [90.2](/filings/0000950170-24-015188.md) | [72.5](/filings/0000950170-24-060398.md) | [45.9](/filings/0001193125-25-223165.md) | [47.3](/filings/0000950170-24-127006.md) | [53.4](/filings/0000950170-25-021129.md) | [62.2](/filings/0000950170-25-072540.md) | [57.8](/filings/0001437749-26-031222.md) | [58.3](/filings/0001193125-25-282845.md) | [81.8](/filings/0001193125-26-051277.md) | [63.7](/filings/0001437749-26-017364.md) | [71.5](/filings/0001437749-26-031222.md) |
| Total assets | $m | [1,108](/filings/0000950170-23-064253.md) | [1,075](/filings/0000950170-24-015188.md) | [1,053](/filings/0000950170-24-060398.md) | [1,021](/filings/0001193125-25-223165.md) | [1,053](/filings/0000950170-24-127006.md) | [1,065](/filings/0000950170-25-021129.md) | [1,074](/filings/0000950170-25-072540.md) | [1,086](/filings/0001437749-26-031222.md) | [1,110](/filings/0001193125-25-282845.md) | [1,143](/filings/0001193125-26-051277.md) | [1,143](/filings/0001437749-26-017364.md) | [1,192](/filings/0001437749-26-031222.md) |
| Total liabilities | $m | [914](/filings/0000950170-23-064253.md) | [877](/filings/0000950170-24-015188.md) | [854](/filings/0000950170-24-060398.md) | [821](/filings/0001193125-25-223165.md) | [852](/filings/0000950170-24-127006.md) | [866](/filings/0000950170-25-021129.md) | [879](/filings/0000950170-25-072540.md) | [893](/filings/0001437749-26-031222.md) | [918](/filings/0001193125-25-282845.md) | [955](/filings/0001193125-26-051277.md) | [959](/filings/0001437749-26-017364.md) | [1,010](/filings/0001437749-26-031222.md) |
| Short-term borrowings | $m | [20.0](/filings/0000950170-23-064253.md) | [20.0](/filings/0000950170-24-015188.md) | not reported | [0.0](/filings/0001193125-25-223165.md) | [20.0](/filings/0000950170-24-127006.md) | [30.0](/filings/0000950170-25-021129.md) | [30.0](/filings/0000950170-25-072540.md) | [30.0](/filings/0001193125-26-051277.md) | [35.0](/filings/0001193125-25-282845.md) | [50.0](/filings/0001193125-26-051277.md) | not reported | not reported |
| Shareholders' equity | $m | [194](/filings/0000950170-25-021129.md) | [198](/filings/0000950170-25-072540.md) | [199](/filings/0000950170-25-072540.md) | [199](/filings/0001437749-26-031222.md) | [201](/filings/0001193125-26-051277.md) | [198](/filings/0001437749-26-017364.md) | [195](/filings/0001437749-26-017364.md) | [194](/filings/0001437749-26-031222.md) | [192](/filings/0001193125-26-051277.md) | [188](/filings/0001437749-26-017364.md) | [184](/filings/0001437749-26-017364.md) | [182](/filings/0001437749-26-031222.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(1,552)](/filings/0000950170-24-127006.md) | [(935) d](/filings/0000950170-25-021129.md) | [(3,923) d](/filings/0000950170-25-072540.md) | [4,671 d](/filings/0001193125-25-223165.md) | [1,789](/filings/0001193125-25-282845.md) | [(1,432) d](/filings/0001193125-26-051277.md) | [2,571 d](/filings/0001437749-26-017364.md) | [1,737 d](/filings/0001437749-26-031222.md) | [1,222](/filings/0001193125-25-282845.md) | [3,592 d](/filings/0001193125-26-051277.md) | [2,009 d](/filings/0001437749-26-017364.md) | [3,880 d](/filings/0001437749-26-031222.md) |
| Capital expenditure | $k | [273](/filings/0000950170-24-127006.md) | [41.0 d](/filings/0000950170-25-021129.md) | [44.0 d](/filings/0000950170-25-072540.md) | [744 d](/filings/0001193125-25-223165.md) | [82.0](/filings/0001193125-25-282845.md) | [101 d](/filings/0001193125-26-051277.md) | [74.0 d](/filings/0001437749-26-017364.md) | [176 d](/filings/0001437749-26-031222.md) | [76.0](/filings/0001193125-25-282845.md) | [494 d](/filings/0001193125-26-051277.md) | [133 d](/filings/0001437749-26-017364.md) | [117 d](/filings/0001437749-26-031222.md) |
| Dividends paid | $k | not reported | not reported | not reported | not reported | [0.0](/filings/0001193125-25-282845.md) | [0.0 d](/filings/0001193125-26-051277.md) | [0.0 d](/filings/0001437749-26-017364.md) | [444 d](/filings/0001437749-26-031222.md) | [429](/filings/0001193125-25-282845.md) | [406 d](/filings/0001193125-26-051277.md) | [394 d](/filings/0001437749-26-017364.md) | [460 d](/filings/0001437749-26-031222.md) |
| Share repurchases | $k | not reported | not reported | not reported | not reported | [737](/filings/0001193125-25-282845.md) | [3,180 d](/filings/0001193125-26-051277.md) | [3,395 d](/filings/0001437749-26-017364.md) | [4,012 d](/filings/0001437749-26-031222.md) | [2,926](/filings/0001193125-25-282845.md) | [4,126 d](/filings/0001193125-26-051277.md) | [4,989 d](/filings/0001437749-26-017364.md) | [3,982 d](/filings/0001437749-26-031222.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2022-09-30) | period not labelled (2022-12-31) | period not labelled (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [0.0](/filings/0000950170-23-064253.md) | [0.0](/filings/0000950170-24-015188.md) | [0.0](/filings/0000950170-24-060398.md) | [1,046](/filings/0000950170-24-127006.md) | [8,768](/filings/0000950170-25-021129.md) | [8,790](/filings/0000950170-25-072540.md) | [8,806](/filings/0001193125-25-282845.md) | [8,591](/filings/0001193125-26-051277.md) | [8,315](/filings/0001437749-26-017364.md) | [7,928](/filings/0001193125-25-282845.md) | [7,695](/filings/0001193125-26-051277.md) | [7,557](/filings/0001437749-26-017364.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 7,931,396 at 2026-09-21, from the cover of the [10-K filed 2026-09-25](/filings/0001437749-26-031222.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.